Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Peter

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Opinion in Lipidology|January 17, 2008
Therapy and clinical trials: diabetes and cardiovascular riskRajesh Peter
Current Opinion in Lipidology|September 9, 2006
Therapy and clinical trialsMuhammad Usman, Rajesh Peter
Current Opinion in Lipidology|November 13, 2007
Fibrate therapy: safety considerationsMuhammad Usman, Rajesh Peter
Current Opinion in Lipidology|March 12, 2009
Diabetes and cardiovascular disease: new perspectivesRajesh Peter, Alan Rees
Expert Opinion on Drug Safety|May 20, 2020
Safety of injectable semaglutide for type 2 diabetesRajesh Peter, Steve C Bain
Current Opinion in Lipidology|March 14, 2013
Hyperlipidaemia and cardiovascular disease -- newer antihyperglycaemic agents and cardiovascular diseaseRajesh Peter, Hammad Bajwa, Sony Anthony
Current Opinion in Lipidology|January 6, 2011
Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?Rajesh Peter, Elizabeth Reilly, Sony Anthony
Current Opinion in Lipidology|January 14, 2012
Diabetes: coronary heart disease equivalent?Rajesh Peter, Anneka Rose, Sony Anthony
BMJ (Clinical Research Ed.)|February 7, 2004
Severe hypocalcaemia after being given intravenous bisphosphonateRajesh Peter, Vinita Mishra, William D Fraser
Clinical Biochemistry|October 21, 2017
Stability of proinsulin in whole bloodDominic J Bright, Gareth J Dunseath, Rajesh Peter, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Opinion in Lipidology|January 17, 2008
Therapy and clinical trials: diabetes and cardiovascular riskRajesh Peter
Current Opinion in Lipidology|September 9, 2006
Therapy and clinical trialsMuhammad Usman, Rajesh Peter
Current Opinion in Lipidology|November 13, 2007
Fibrate therapy: safety considerationsMuhammad Usman, Rajesh Peter
Current Opinion in Lipidology|March 12, 2009
Diabetes and cardiovascular disease: new perspectivesRajesh Peter, Alan Rees
Expert Opinion on Drug Safety|May 20, 2020
Safety of injectable semaglutide for type 2 diabetesRajesh Peter, Steve C Bain
Current Opinion in Lipidology|March 14, 2013
Hyperlipidaemia and cardiovascular disease -- newer antihyperglycaemic agents and cardiovascular diseaseRajesh Peter, Hammad Bajwa, Sony Anthony
Current Opinion in Lipidology|January 6, 2011
Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?Rajesh Peter, Elizabeth Reilly, Sony Anthony
Current Opinion in Lipidology|January 14, 2012
Diabetes: coronary heart disease equivalent?Rajesh Peter, Anneka Rose, Sony Anthony
BMJ (Clinical Research Ed.)|February 7, 2004
Severe hypocalcaemia after being given intravenous bisphosphonateRajesh Peter, Vinita Mishra, William D Fraser
Clinical Biochemistry|October 21, 2017
Stability of proinsulin in whole bloodDominic J Bright, Gareth J Dunseath, Rajesh Peter, et al.
Pageof 3